5-叔-丁基-2,4-二羟基苯并苯基酮 | 4211-67-0

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-叔-丁基-2,4-二羟基苯并苯基酮
• 中文别名: 5-叔丁基-2,4-二羟基二苯酮
• 英文名称: 2,4-dihydroxy-5-tert-butylbenzophenone
• 英文别名: (5-tert-butyl-2,4-dihydroxyphenyl)-phenylmethanone
• CAS: 4211-67-0
• 化学式: C₁₇H₁₈O₃
• mdl: MFCD01861910
• 分子量: 270.328
• InChiKey: HSYUVRRTSSSDJI-UHFFFAOYSA-N

物化性质

• 熔点：
  145-148 °C (lit.)
• 沸点：
  373.44°C (rough estimate)
• 密度：
  1.1141 (rough estimate)
• 稳定性/保质期：

  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.235
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2914501900

文献信息

• Epoxy resins containing bound light stabilizing groups
  申请人：ELF ATOCHEM NORTH AMERICA, INC.

  公开号：EP0507333A2

  公开（公告）日：1992-10-07

  Curable compositions which are precursors for cured or partially cured light stabilized epoxy resins which are the product of the reaction of some or all of the epoxy groups of an epoxy resin with an N-(2,2,6,6-tetraalkyl-4-piperidinyl)amic acid hydrazide as well as the cured or partially cured reaction products thereof together with processes for their use and articles of manufacture produced thereby are disclosed.

  本发明公开了作为固化或部分固化光稳定环氧树脂前体的可固化组合物，这些组合物是环氧树脂的部分或全部环氧基团与 N-(2,2,6,6-四烷基-4-哌啶基)胺酸酰肼反应的产物，以及其固化或部分固化反应产物及其使用工艺和由此生产的制品。
• FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
  申请人：Arbiser Jack L.

  公开号：US20080275016A1

  公开（公告）日：2008-11-06

  Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are fulvene and/or fulvalene analogs. The compounds and compositions can be used to treat and/or prevent a wide variety of cancers, including drug resistant cancers, as well as numerous inflammatory, degenerative and vascular diseases, including various ocular diseases. Representative fulvene and/or fulvalene analogs include fulvene and fulvalene analogues of various dyes, hormones, sugars, peptides, oligonucleotides, amino acids, nucleotides, nucleosides, and polyols. The compounds are believed to function, at least, by inhibiting Nox or ROS. In some embodiments, the Nox is one that is selectively expressed in cancer cells over normal cells, or one that is expressed in higher amounts in cancer cells over normal cells. Thus, the compounds are novel therapeutic agents for a variety of cancers and other diseases.
• US5213897A
  申请人：——

  公开号：US5213897A

  公开（公告）日：1993-05-25
• US5318851A
  申请人：——

  公开号：US5318851A

  公开（公告）日：1994-06-07
• US8841276B2
  申请人：——

  公开号：US8841276B2

  公开（公告）日：2014-09-23